Author: Freemantle N. Mason J.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.17, Iss.4, 2000-04, pp. : 319-324
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Aalto-Setälä Ville Kanerva Risto Bell J. Simon
International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. :
Betacarotene, tocopherol: no additional cardiovascular benefits
Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. :
Infliximab: additional benefits in Crohn's disease
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
"Reasonable cost" for chlamydia screening in young adults
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 496, 2006-01 ,pp. :